Abstract
Malignant tumors of the eyelids and ocular surface are common ocular malignancies. At present, surgical treatment is mostly the first choice for these types of tumors. However, postoperative tumor recurrence and metastasis are still regarded as failures in the treatment of such malignancies. Based on this, malignant tumors of the eyelid and ocular surface are sometimes accompanied by local adjuvant chemotherapy and systemic chemotherapy to treat patients with relapse, invasion of adjacent tissues, and systemic metastases. Still, drug resistance greatly affects the treatment effect. This review lists several mechanisms of recurrence and metastasis of ocular surface and eyelid tumors after surgery, as well as mechanisms that may lead to non-surgical treatment or drug resistance.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Neuro-Signals |
| Jahrgang | 30 |
| Ausgabenummer | S1 |
| Seiten (von - bis) | 21-38 |
| Seitenumfang | 18 |
| ISSN | 1424-862X |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 25.08.2022 |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Strategische Forschungsbereiche und Zentren
- Profilbereich: Lübeck Integrated Oncology Network (LION)
- Zentren: Universitäres Cancer Center Schleswig-Holstein (UCCSH)
DFG-Fachsystematik
- 2.23-11 Augenheilkunde
- 2.22-14 Hämatologie, Onkologie
Fingerprint
Untersuchen Sie die Forschungsthemen von „Therapy Failure and Resistance Mechanism in Eyelid and Ocular Surface Tumors“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver